Literature DB >> 34554524

Coffee extracts effectively inhibit the formation of α-chymotrypsin amyloid-like fibrils in aqueous ethanol in vitro.

Márta Kotormán1,2, Vanda Andrea Bedő3.   

Abstract

In this study, an in vitro α-chymotrypsin aggregation model was used to demonstrate that certain extracts of commercial coffees effectively inhibit protein aggregation in 55% ethanol at pH 7.0. To detect the anti-amyloidogenic effect of the various coffee extracts, turbidity measurements and Congo red binding assays were performed as well as the determination of the total polyphenol content of the extracts. The greatest fibril formation inhibitory effect was exerted by the Eduscho coffee extract, which contained also the most of the phenolic compounds. The Eduscho coffee extract inhibited the fibrillation of the α-chymotrypsin dose dependently. Coffee extracts are effective anti-aggregation agents, and their beneficial effects strongly correlate with the total phenolic content.
© 2020. The Author(s).

Entities:  

Keywords:  Amyloid fibrils; Coffee; Congo red; Polyphenols; α-Chymotrypsin

Mesh:

Substances:

Year:  2020        PMID: 34554524     DOI: 10.1007/s42977-020-00006-8

Source DB:  PubMed          Journal:  Biol Futur        ISSN: 2676-8607


  33 in total

Review 1.  Amyloid formation by globular proteins under native conditions.

Authors:  Fabrizio Chiti; Christopher M Dobson
Journal:  Nat Chem Biol       Date:  2009-01       Impact factor: 15.040

Review 2.  Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases.

Authors:  Biao Cheng; Hao Gong; Hongwen Xiao; Robert B Petersen; Ling Zheng; Kun Huang
Journal:  Biochim Biophys Acta       Date:  2013-06-29

3.  Modulation of amyloid fibril formation of plasma protein by saffron constituent "safranal": Spectroscopic and imaging analyses.

Authors:  Mohd Sajid Ali; Hamad A Al-Lohedan; Mohammad Tariq; Mohammad Abul Farah; Mohammad Altaf; S M Wabaidur; S M Shakeel Iqubal; Sartaj Tabassum; Mahmood M S Abdullah
Journal:  Int J Biol Macromol       Date:  2019-01-14       Impact factor: 6.953

4.  Anti-fibrillation propensity of a flavonoid baicalein against the fibrils of hen egg white lysozyme: potential therapeutics for lysozyme amyloidosis.

Authors:  Naveed Ahmad Fazili; Imtiyaz Ahmad Bhat; Waseem Feeroze Bhat; Aabgeena Naeem
Journal:  J Biomol Struct Dyn       Date:  2016-02-26

5.  Coffee components inhibit amyloid formation of human islet amyloid polypeptide in vitro: possible link between coffee consumption and diabetes mellitus.

Authors:  Biao Cheng; Xinran Liu; Hao Gong; Lianqi Huang; Hong Chen; Xin Zhang; Chuanzhou Li; Muyang Yang; Bingjun Ma; Lihua Jiao; Ling Zheng; Kun Huang
Journal:  J Agric Food Chem       Date:  2011-11-21       Impact factor: 5.279

6.  Trigonelline protects hippocampus against intracerebral Aβ(1-40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms.

Authors:  Javad Fahanik-Babaei; Tourandokht Baluchnejadmojarad; Farnaz Nikbakht; Mehrdad Roghani
Journal:  Metab Brain Dis       Date:  2018-11-12       Impact factor: 3.584

7.  Vanillin restrains non-enzymatic glycation and aggregation of albumin by chemical chaperone like function.

Authors:  Saurabh Awasthi; N T Saraswathi
Journal:  Int J Biol Macromol       Date:  2016-02-15       Impact factor: 6.953

8.  Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice.

Authors:  Chuanhai Cao; Li Wang; Xiaoyang Lin; Malgorzata Mamcarz; Chi Zhang; Ge Bai; Jasson Nong; Sam Sussman; Gary Arendash
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 9.  An outlook on the role of decaffeinated coffee in neurodegenerative diseases.

Authors:  Raffaella Colombo; Adele Papetti
Journal:  Crit Rev Food Sci Nutr       Date:  2019-01-07       Impact factor: 11.176

10.  Vitamin k3 inhibits protein aggregation: Implication in the treatment of amyloid diseases.

Authors:  Parvez Alam; Sumit Kumar Chaturvedi; Mohammad Khursheed Siddiqi; Ravi Kant Rajpoot; Mohd Rehan Ajmal; Masihuz Zaman; Rizwan Hasan Khan
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.